Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial
Gonasagrie Nair, Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne A. Akello, Rita Nakalega, Pippa Macdonald, Gakiema Milan, Thesla Palanee‐Phillips, Krishnaveni Reddy, Eunice Tahuringana, Felix Muhlanga, Clemensia Nakabiito, Linda‐Gail Bekker, Bekezela Siziba, Sharon L. Hillier, Jared M. Baeten, Morgan Garcia, Sherri Johnson, Tara McClure, Lisa Levy, Edward Livant, Cindy Jacobson, Lydia Soto-Torres, Ariane van der Straten, Sybil Hosek, James F. Rooney, John Steytler, Katherine Bunge, Urvi M. Parikh, Craig W. Hendrix, Peter L. Anderson, Kenneth Ngure
Topics & Concepts
MedicineVaginal ringPre-exposure prophylaxisEmtricitabineClinical endpointMicrobicides for sexually transmitted diseasesRandomized controlled trialObstetricsHuman immunodeficiency virus (HIV)Internal medicineMen who have sex with menFamily planningPopulationViral loadEnvironmental healthFamily medicineAntiretroviral therapyResearch methodologySyphilisHealth servicesHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentAdolescent Sexual and Reproductive Health